17 alpha-hydroxylase deficiency differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 25: | Line 25: | ||
| | | | ||
|- | |- | ||
|Disorders with abnormal testicular activity | | rowspan="4" |Disorders with abnormal testicular activity | ||
|'''Gonadal dysgenesis''' | |||
| | |||
| | |||
|. | |||
|- | |||
|'''Testicular regression syndrome''' | |||
| | |||
| | |||
| | |||
|- | |||
|'''Vanishing testes syndrome''' | |||
| | |||
| | |||
| | |||
|- | |||
|'''Persistent Müllerian duct syndrome''' | |||
| | |||
| | |||
| | |||
|- | |||
| rowspan="4" |Disorders with abnormal androgen synthesis or response | |||
|Abnormal androgen synthesis | |||
| | |||
| | |||
| | |||
|- | |||
|'''5-alpha-reductase type 2 deficiency''' | |||
| | |||
| | |||
| | |||
|- | |||
|Abnormal response to androgens | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 15:44, 4 August 2017
17 alpha-hydroxylase deficiency Microchapters |
Differentiating 17 alpha-hydroxylase deficiency from other Diseases |
Diagnosis |
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency differential diagnosis |
FDA on 17 alpha-hydroxylase deficiency differential diagnosis |
CDC on 17 alpha-hydroxylase deficiency differential diagnosis |
17 alpha-hydroxylase deficiency differential diagnosis in the news |
Blogs on 17 alpha-hydroxylase deficiency differential diagnosis |
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency must be differentiated from other diseases that cause similar clinical features, such as 5-alpha-reductase deficiency and hypogonadism.[1]
Differentiating 17 alpha-hydroxylase deficiency from other Diseases
17 alpha-hydroxylase deficiency must be differentiated from diseases with undervirilization in males. These diseases include androgen insensitivity syndrome,
Disease name | . | . | . | |
---|---|---|---|---|
Androgen insensitivity syndrome | ||||
3-beta-hydroxysteroid dehydrogenase type 2 deficiency | ||||
Disorders with abnormal testicular activity | Gonadal dysgenesis | . | ||
Testicular regression syndrome | ||||
Vanishing testes syndrome | ||||
Persistent Müllerian duct syndrome | ||||
Disorders with abnormal androgen synthesis or response | Abnormal androgen synthesis | |||
5-alpha-reductase type 2 deficiency | ||||
Abnormal response to androgens | ||||
References
- ↑ Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. Wikipedia (2016. https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency Accessed on February 4, 2016